Defense against filoviruses used as biological weapons

Mike Bray1

  • 1Medical Officer, Biodefense Clinical Research Branch, OCR/OD/NIAID/NIH, 6700A Rockledge Drive, Room 5132, Bethesda, MD 20892, USA. mbray@niaid.nih.gov

Antiviral Research
|March 5, 2003
PubMed

Insights

Filoviruses like Ebola and Marburg are dangerous biowarfare agents. While airborne in labs, human transmission requires direct contact, allowing containment through isolation and infection control.

Area of Science:

  • Virology
  • Infectious Diseases
  • Biodefense

Background:

  • Filoviruses, including Marburg and Ebola, are Category A biowarfare agents.
  • Infections are often fatal, with no current vaccines or therapies.
  • Laboratory studies show high airborne infectivity, but human transmission requires direct contact.

Purpose of the Study:

  • To review the characteristics of filoviruses as biowarfare agents.
  • To discuss transmission, containment, and diagnostic challenges.
  • To emphasize the importance of accurate information in preventing panic.

Main Methods:

  • Review of scientific literature on filovirus outbreaks and laboratory studies.
  • Analysis of transmission routes and infection control strategies.
  • Assessment of biowarfare threat and countermeasure development.

Main Results:

  • Person-to-person filovirus spread necessitates direct contact with infectious material.
  • Standard infection control and patient isolation effectively halt epidemics.
  • Diagnosis requires specialized biocontainment laboratory studies due to symptom overlap with other hemorrhagic fevers.

Conclusions:

  • Filovirus epidemics can be controlled with established public health measures.
  • Development of vaccines and therapies is ongoing but limited by biocontainment facility availability.
  • Accurate information is crucial for mitigating public fear and preventing panic during potential biowarfare events.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...